Skip to Content
Questions about Atrial Fibrillation? Get answers from our expert.

Hydralazine / isosorbide dinitrate Pregnancy and Breastfeeding Warnings

Hydralazine / isosorbide dinitrate is also known as: BiDil

Hydralazine / isosorbide dinitrate Pregnancy Warnings

Hydralazine animal studies have revealed evidence of teratogenicity. Isosorbide dinitrate animal studies have revealed evidence of embryotoxicity. A meta-analysis of randomized controlled trials comparing hydralazine to other antihypertensive agents for severe hypertension in pregnancy found that hydralazine was associated with significantly more maternal hypotension, placental abruption, caesarean sections, and oliguria, with more adverse effects on fetal heart rate and with lower Apgar scores. There are no controlled data for isosorbide dinitrate in human pregnancy. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. US FDA pregnancy category: C

Hydralazine / isosorbide dinitrate Breastfeeding Warnings

The manufacturer makes no recommendation regarding use during lactation. Excreted into human milk: Yes (hydralazine); Unknown (isosorbide dinitrate) Excreted into animal milk: Data not available (isosorbide dinitrate) Comments: The effects in the nursing infant are unknown.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.